Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Unknown 15Completed 3

Sponsor Class

OTHER 440INDUSTRY 221NIH 33NETWORK 30OTHER_GOV 8UNKNOWN 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 1

Interventions

S 1 (combination) 7Cisplatin 7Radiotherapy, Intensity-Modulated 5Paclitaxel 5Oxaliplatin 3Irinotecan 3Capecitabine 3titanium silicide 2raltitrexed 2nimotuzumab 2nabiximols 2Radiotherapy 2Radiation Dose Hypofractionation 2pegylated granulocyte colony-stimulating factor 1nedaplatin 1icaritin 1gimeracil 1anlotinib 1Trastuzumab 1Temozolomide 1Tegafur 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Pemetrexed 1Ondansetron 1Methylene Blue 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × UNKNOWN × Capecitabine × Clear all
NCT04247984 2022-03-11

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

ChineseAMS

Phase 2 Completed
264 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01584544 2015-04-20

Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer

ChineseAMS

Phase 1 Completed
24 enrolled 10 charts
Gastrointestinal

Rectal Neoplasms

NCT01268943 2015-04-06

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

ChineseAMS

Phase 1 Completed
18 enrolled 10 charts
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡